BIOLASE (BIOL) Competitors $0.01 0.00 (-0.83%) As of 04/17/2025 Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock BIOL vs. NAYA, AFIB, HSDT, NVIVQ, DYNT, LGMK, CUTR, SONX, STSS, and GMVDFShould you be buying BIOLASE stock or one of its competitors? The main competitors of BIOLASE include NAYA Biosciences (NAYA), Acutus Medical (AFIB), Helius Medical Technologies (HSDT), Invivo Therapeutics (NVIVQ), Dynatronics (DYNT), LogicMark (LGMK), Cutera (CUTR), Sonendo (SONX), Sharps Technology (STSS), and G Medical Innovations (GMVDF). These companies are all part of the "medical equipment" industry. BIOLASE vs. NAYA Biosciences Acutus Medical Helius Medical Technologies Invivo Therapeutics Dynatronics LogicMark Cutera Sonendo Sharps Technology G Medical Innovations NAYA Biosciences (NASDAQ:NAYA) and BIOLASE (NASDAQ:BIOL) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, analyst recommendations, dividends, community ranking and media sentiment. Do analysts rate NAYA or BIOL? NAYA Biosciences currently has a consensus price target of $24.00, indicating a potential upside of 1,150.00%. BIOLASE has a consensus price target of $1.20, indicating a potential upside of 9,900.00%. Given BIOLASE's higher possible upside, analysts plainly believe BIOLASE is more favorable than NAYA Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NAYA Biosciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00BIOLASE 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Does the MarketBeat Community prefer NAYA or BIOL? BIOLASE received 291 more outperform votes than NAYA Biosciences when rated by MarketBeat users. However, 100.00% of users gave NAYA Biosciences an outperform vote while only 51.41% of users gave BIOLASE an outperform vote. CompanyUnderperformOutperformNAYA BiosciencesOutperform Votes1100.00% Underperform VotesNo VotesBIOLASEOutperform Votes29251.41% Underperform Votes27648.59% Do insiders and institutionals hold more shares of NAYA or BIOL? 12.0% of NAYA Biosciences shares are held by institutional investors. Comparatively, 8.8% of BIOLASE shares are held by institutional investors. 1.8% of NAYA Biosciences shares are held by insiders. Comparatively, 0.3% of BIOLASE shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has stronger earnings and valuation, NAYA or BIOL? NAYA Biosciences has higher earnings, but lower revenue than BIOLASE. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNAYA Biosciences$6.23M0.21-$8.03MN/AN/ABIOLASE$48.83M0.01-$20.63M-$14.940.00 Which has more volatility & risk, NAYA or BIOL? NAYA Biosciences has a beta of 2.03, suggesting that its share price is 103% more volatile than the S&P 500. Comparatively, BIOLASE has a beta of 0.67, suggesting that its share price is 33% less volatile than the S&P 500. Does the media prefer NAYA or BIOL? In the previous week, NAYA Biosciences had 3 more articles in the media than BIOLASE. MarketBeat recorded 3 mentions for NAYA Biosciences and 0 mentions for BIOLASE. NAYA Biosciences' average media sentiment score of 0.00 equaled BIOLASE'saverage media sentiment score. Company Overall Sentiment NAYA Biosciences Neutral BIOLASE Neutral Is NAYA or BIOL more profitable? BIOLASE has a net margin of -41.65% compared to NAYA Biosciences' net margin of -119.91%. NAYA Biosciences' return on equity of 0.00% beat BIOLASE's return on equity.Company Net Margins Return on Equity Return on Assets NAYA Biosciences-119.91% N/A -41.72% BIOLASE -41.65%-1,782.73%-55.31% SummaryNAYA Biosciences beats BIOLASE on 10 of the 15 factors compared between the two stocks. Get BIOLASE News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIOL vs. The Competition Export to ExcelMetricBIOLASEDental equipment & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$401,000.00$3.73B$5.30B$7.34BDividend YieldN/A2.63%5.12%4.30%P/E Ratio0.0041.7921.8617.80Price / Sales0.011.37380.5497.75Price / CashN/A6.5738.2634.64Price / Book-0.170.586.453.98Net Income-$20.63M-$153.72M$3.22B$247.81M7 Day PerformanceN/A0.03%2.85%1.80%1 Month PerformanceN/A-18.38%-8.67%-6.81%1 Year PerformanceN/A-33.67%11.46%1.31% BIOLASE Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIOLBIOLASE0.7726 of 5 stars$0.01-0.8%$1.20+9,900.0%-91.8%$401,000.00$48.83M0.00160NAYANAYA BiosciencesN/A$2.10+14.6%$24.00+1,044.8%N/A$1.40M$6.23M0.0010News CoverageGap UpHigh Trading VolumeAFIBAcutus MedicalN/A$0.04+14.4%N/A-73.9%$1.33M$7.16M0.00340HSDTHelius Medical Technologies1.068 of 5 stars$0.34-14.1%N/A-94.7%$1.25M$520,000.00-0.0530Short Interest ↓Gap DownNVIVQInvivo TherapeuticsN/A$0.37flatN/AN/A$1.15MN/A0.006High Trading VolumeDYNTDynatronicsN/A$0.11+3.8%N/A-85.3%$969,000.00$33.60M-0.13200High Trading VolumeLGMKLogicMark0.6617 of 5 stars$0.01-10.1%N/A-100.0%$812,000.00$9.90M0.0020Short Interest ↑Gap DownHigh Trading VolumeCUTRCutera1.289 of 5 stars$0.04-63.9%$3.00+7,592.3%-98.4%$787,000.00$155.21M-0.01460Gap DownHigh Trading VolumeSONXSonendoN/A$1.31+4.8%N/A+1,247.8%$559,000.00$44.40M-0.02250Gap UpSTSSSharps Technology0.4201 of 5 stars$0.02-22.5%N/AN/A$327,000.00N/A0.003Short Interest ↑News CoveragePositive NewsGap DownHigh Trading VolumeGMVDFG Medical InnovationsN/A$0.00flatN/A-98.7%$52,000.00$4.42M0.0072News Coverage Related Companies and Tools Related Companies NAYA Biosciences Alternatives Acutus Medical Alternatives Helius Medical Technologies Alternatives Invivo Therapeutics Alternatives Dynatronics Alternatives LogicMark Alternatives Cutera Alternatives Sonendo Alternatives Sharps Technology Alternatives G Medical Innovations Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BIOL) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | Sponsored100-year-old investment secret predicts what?!A 100-year-old indicator has quietly predicted nearly every major market meltdown — including the Dot-Com Bust...Weiss Ratings | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BIOLASE, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BIOLASE With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
